Clinical Trial

Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM

Study acronym: PROACAROS
Unknown Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The trial is performed to assess efficacy and safety of Beltavac with polymerized extract of house dust mites in allergic Rhinoconjunctivitis associated or not with asthma
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05395689
Lead Sponsor Probelte Pharma S.L.U.
Conditions House Dust Mite Allergy
Enrollment 350 participants
Start Date 2022-01-17
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2024-07-18